| CECIL |
| TEXT BOOK of MEDICINE |
Section XII Gastrointestinal Diseases
143 APPROACH TO THE PATIENT WITH DIARRHEA AND MALABSORPTION
Carol E. Semrad and Don W. Powell • |
REFERENCES
- McFarland LV: Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101:812–822.
- Lucas Me, Dean JL, von Seidlain, et al: Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 2005;32:757–767.
- Dupont HL, Jiang ZD, Okhuysen PC, et al: A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 2005;142:805–812.
- Dupont HL, Jiang ZD, Belkind-Gerson J, et al: Treatment of traveler's diarrhea: Randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin Gastroenterol Hepatol 2007;5:451–456.
- Di Stefano M, Malservisi S, Veneto G, et al: Rifaximin versus chlortetracycline in the short-term treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther 2000;14:551–556.
- Byrne TA, Wilmore DW, Iyer K, et al: Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: A prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg 2005;242:655–661.
- Chey WD, Chey WY, Heath AT, et al: Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2004;99:2195–2203.
